Home | Welcome to Contract Pharma   
Last Updated Thursday, October 30 2014
Print

Financial Report: Thermo Fisher Scientific



Published January 31, 2013
Thermo Fisher Scientific

4Q Revenues: $3.3 billion (+6%)

4Q Earnings: $376.4 million (+12%)

FY Revenues: $12.5 billion (+8%)

FY Earnings: $1.2 billion (+9%)

Comments: Analytical Technologies Segment revenue was up 2% to $1.1 billion in the quarter. Specialty Diagnostics Segment revenue increased 12% to $792 million. Laboratory Products and Services Segment revenue increased 4% to $1.5 billion.


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On